System Transmission

Top Signal

100#1 JOB

Activity

2178Ripe

+919 today

System

Livenow

Terminal Asset View

stockNASDAQ

ARCT

$6.68-4.57%

Arcturus Therapeutics Holdings Inc

Overripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

13Overripe

Live Analysis Active

Company Mission

Arcturus Therapeutics creates messenger RNA medicines that target respiratory diseases like influenza and COVID-19. Their technology delivers genetic instructions to cells to produce therapeutic proteins. The company makes money through research partnerships with pharmaceutical companies and could earn revenue from future drug sales if their treatments get approved.

ARC

Industry Context

The biotechnology industry focuses on developing medical treatments using biological systems. Companies in this space often have no products yet but work on promising therapies. Investors watch for clinical trial results and partnership announcements that can dramatically move stock prices.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

62Matrix

Market Momentum

36.5— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.0x— Normal Volume

Today's Change

-4.57%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ARCT across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 04:54 PM UTC

As-of 03-15-2026 16:39 UTC

Develops messenger RNA medicines for treating diseases and makes money by partnering with drug companies to advance these therapies.

Price below key moving averages for several weeks, suggesting a downtrend as sellers dominate the momentum showing consolidation pattern.

Biotech sector showing volatility as investors rotate between growth and safety, creating choppy trading conditions for development-stage, suggesting for development-stage.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...